The VALIDATE PhD Showcase offers a unique opportunity for PhD students to improve their presentation skills and share their research with an international network of peers. The online event features quick-fire presentations followed by interactive workshops with senior VALIDATE Investigators. Registration is now open for the event on September 12, 2023, at 15:00 BST.
Don't miss this chance to network, collaborate, and gain valuable feedback for future presentations - www.validate-network.org/event/phd-showcase
- Long-acting vaccine delivery systems, Walvekar P et al, in Advanced Drug Delivery
- Central nervous system tuberculosis immunopathology is driven by matrix destruction with matrix metalloproteinases inhibition reducing inflammation and improving survival, Poh XY et al, in International Journal of Infectious Diseases
- A molecular and immunological signature of cd4 + t cells in post kala-azar dermal leishmaniasis, Kumar A et al, in International Journal of Infectious Diseases.
- Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates, Wang R et al, in Vaccine
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
TB cases continue to rise in Canada, Zendal and IAVI partner on the development of MTBVAC, and the BCG Vaccine might be protective against Alzheimer’s. The Quratis' novel TB vaccine has been confirmed safe in a phase 2 study, Opera News Nigeria shared an analysis of TB reduction in the country, and the Stop TB Partnership held an engagement session called From Innovation to Implementation: Preparing now for new tools to End TB. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter..
Published: 24 May 2023